Hot Topics in the Surgical Treatment of Intrahepatic Cholangiocarcinoma: A Narrative Review of Current Managements
Cancers · 26.09.2025 · 17 (19) · 3127
DOI: 10.3390/cancers17193127 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 26.09.2025. Verfasst von Silvio Caringi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Università Degli Studi Roma "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary liver cancer with a poor prognosis. Negative-margin resection is presently the only potentially curative treatment option. Emerging trends with direct applicability to surgical strategy include margin thickness, lymphadenectomy, optimization of future liver remnant (FLR), minimally invasive techniques, incorporation of systemic therapy, and reconsideration of liver transplantation. This review emphasizes areas of consensus and ongoing debate. Margins ≥5–10 mm are associated with improved results, but biology generally takes precedence over prognosis. Regional lymphadenectomy enhances staging accuracy, although its therapeutic benefit remains unsettled. PVE is standard for FLR enlargement, LVD provides faster hypertrophy, and ALPPS remains reserved for highly selective cases. Minimally invasive and robotic hepatectomy share oncologic results in skilled institutions. Systemic therapies, including immunotherapy and biomarker-directed targeted therapy, are increasingly being incorporated perioperatively. Liver transplant may be of potential value in early-stage disease or on strict indications after neoadjuvant treatment. The modern surgical management of iCCA encompasses a blend of oncologic considerations, FLR optimization, minimally invasive surgery, and systemic therapy according to tumor biology. Multidisciplinary planning and participation in clinical trials are necessary to align surgical innovation with advancements in molecular and systemic treatments, ultimately leading to improved long-term outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Università Degli Studi Roma "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.
- Unit of Hepato-Biliary and Pancreatic Surgery, "F. Miulli" General Hospital, Acquaviva delle Fonti, 70021 Bari, Italy.
- Department of Radiology, "F. Miulli" General Hospital, Acquaviva delle Fonti, 70021 Bari, Italy.
- Interventional Radiology Unit, "F. Miulli" General Hospital, Acquaviva delle Fonti, 70021 Bari, Italy.
- Transplant and HPB Unit, Department of Surgery Sciences, University of Rome Tor Vergata, 00133 Rome, Italy.
- Department of Medicine and Surgery, LUM University, Casamassima, 70010 Bari, Italy.
ORCID-Profile: Silvio Caringi, Antonella Delvecchio, Roberto Calbi, Tommaso Maria Manzia, Michele Tedeschi, Riccardo Inchingolo, Riccardo Memeo
Zitieren
APA
Caringi, S., Delvecchio, A., Casella, A., Ferraro, V., Dezio, M., Marini, S., Calbi, R., Cortese, F., Filippo, R., Stasi, M., Manzia, T. M., Tedeschi, M., Inchingolo, R., & Memeo, R. (2025). Hot Topics in the Surgical Treatment of Intrahepatic Cholangiocarcinoma: A Narrative Review of Current Managements. Cancers, 17(19), 3127. https://doi.org/10.3390/cancers17193127
Vancouver
Caringi S, Delvecchio A, Casella A, Ferraro V, Dezio M, Marini S, et al. Hot Topics in the Surgical Treatment of Intrahepatic Cholangiocarcinoma: A Narrative Review of Current Managements. Cancers. 2025;17(19):3127. doi:10.3390/cancers17193127
BibTeX
@article{Caringi2025,
author = {Caringi, Silvio and Delvecchio, Antonella and Casella, Annachiara and Ferraro, Valentina and Dezio, Michele and Marini, Stefania and Calbi, Roberto and Cortese, Francesco and Filippo, Rosalinda and Stasi, Matteo and Manzia, Tommaso Maria and Tedeschi, Michele and Inchingolo, Riccardo and Memeo, Riccardo},
title = {Hot Topics in the Surgical Treatment of Intrahepatic Cholangiocarcinoma: A Narrative Review of Current Managements},
journal = {Cancers},
year = {2025},
volume = {17},
number = {19},
pages = {3127},
doi = {10.3390/cancers17193127}
}
EUVIMED